Richard Kozarek 2024: Editorial: Does ESWL-ERCP for pancreatic duct stone removal change the natural course of symptomatic chronic calcific pancreatitis?

Richard Kozarek
Virginia Mason Medical Center, Seattle, Washington, USA.

Continue reading
0

Chris Ho-Ming Wong et al., 2024: Risk factors of hematoma after SWL for renal calculi: analysis from RCTs and a literature review

Chris Ho-Ming Wong 1, Ivan Ching-Ho Ko 1, Emmy Sui-Fan Tang 1, Steffi Kar-Kei Yuen 1, David Ka-Wai Leung 1, Angel Wing-Yan Kong 1, Peter Ka-Fung Chiu 1, Jeremy Yuen-Chun Teoh 1 2 3, Chi Fai Ng 4
1Department of Surgery, SH Ho Urology Centre, The Chinese University of Hong Kong, Clinical Sciences Building, Prince of Wales, Hospital, New Territories, Hong Kong SAR.
2Department of Urology, Medical University of Vienna, Vienna, Austria.
3Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
4Department of Surgery, SH Ho Urology Centre, The Chinese University of Hong Kong, Clinical Sciences Building, Prince of Wales, Hospital, New Territories, Hong Kong SAR.

Continue reading
0

Emilien Seizilles de Mazancourt et al., 2024: Evaluation of a urinary filtration device for kidney stone retrieval: Pi-Box®

Emilien Seizilles de Mazancourt 1, Nora Jamali 2, Geoffroy de Sallmard 2, Hubert de Bayser 2, Xavier Matillon 2, Nadia Abid 2
1Department of Urology, Saint-Louis University Hospital, Paris, France.
2Department of Urology and Transplant Surgery, Edouard-Herriot Hospital, Lyon, France.

Continue reading
0

Ben H Chew et al., 2024: Break Wave Lithotripsy for Urolithiasis: Results of the First-in-Human International Multi-Institutional Clinical Trial

Ben H Chew 1, Jonathan D Harper 2, Roger L Sur 3, Thomas Chi 4, Shubha De 5, Anne R Buckley 6, Ryan F Paterson 1, Victor K F Wong 1, Connor M Forbes 1, M Kennedy Hall 7, Ross Kessler 7, Seth K Bechis 3, Jason R Woo 3, Ralph C Wang 8, David B Bayne 4, Derek Bochinski 5, Trevor D Schuler 5, Tim A Wollin 5, Rahim Samji 5, Mathew D Sorensen 2
1Department of Urological Sciences, University of British Columbia, Stone Centre at Vancouver General Hospital, Vancouver, British Columbia, Canada.
2Department of Urology, University of Washington School of Medicine, Seattle, Washington.
3Department of Urology, University of California San Diego, San Diego, California.
4Department of Urology, University of California San Francisco, San Francisco, California.
5Department of Urology, University of Alberta, Edmonton, Alberta, Canada.
6Department of Radiology, University of British Columbia, Stone Centre at Vancouver General Hospital, Vancouver, British Columbia, Canada.
7Department of Emergency Medicine, University of Washington School of Medicine, Seattle, Washington.
8Department of Emergency Medicine, University of California San Francisco, San Francisco, California.

Continue reading
0

Yu Liu et al., 2024: Safety evaluation of extracorporeal shockwave lithotripsy for pancreatic stones: Experience based on a large chronic pancreatitis cohort

Yu Liu 1, Jin-Hui Yi 2, Peng-Yuan Wang 3, Peng Fu 4, Ying Kang 5, Teng Wang 2, Di Zhang 2, Xi-Hong Zhang 6, Jin-Jie Xu 2, Song-Lin Zhang 2, Pei-Dong Han 2, Fan Wang 2, Xiao-Yu Zhou 2, Jia-Sheng Feng 2, Jia-Jun Xu 2, Jia-Hao Qian 2, Dan Wang 2, Hui Chen 2, Run-Hui Liu 7, Fang-Yu Wang 8, Zhao-Shen Li 9, Liang-Hao Hu 10
1Department of Gastroenterology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210000, Jiangsu, China; Department of Gastroenterology, Changhai Clinical Research Unit, Changhai Hospital; National Key Laboratory of Immunity and Inflammation, Naval Medical University, Shanghai, 200433, China; Shanghai Institute of Pancreatic Diseases, Shanghai, 200433, China; Department of Pharmacology, College of Pharmacy, Naval Medical University, Shanghai, 200433, China.
2Department of Gastroenterology, Changhai Clinical Research Unit, Changhai Hospital; National Key Laboratory of Immunity and Inflammation, Naval Medical University, Shanghai, 200433, China; Shanghai Institute of Pancreatic Diseases, Shanghai, 200433, China.
3Department of Gastroenterology, Changhai Clinical Research Unit, Changhai Hospital; National Key Laboratory of Immunity and Inflammation, Naval Medical University, Shanghai, 200433, China; Shanghai Institute of Pancreatic Diseases, Shanghai, 200433, China; Department of Gastroenterology, the 981st Hospital of PLA, Chengde, 067000, Hebei, China.
4Department of Pharmacy, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
5Department of Gastroenterology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210000, Jiangsu, China.
6Department of Gastroenterology, The Second Hospital of Shandong University, Jinan, 250012, Shandong, China; Department of Critical Care Medicine, Liaocheng People's Hospital, Liaocheng, 252000, Shandong, China.
7Department of Pharmacology, College of Pharmacy, Naval Medical University, Shanghai, 200433, China.
8Department of Gastroenterology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210000, Jiangsu, China.
9Department of Gastroenterology, Changhai Clinical Research Unit, Changhai Hospital; National Key Laboratory of Immunity and Inflammation, Naval Medical University, Shanghai, 200433, China; Shanghai Institute of Pancreatic Diseases, Shanghai, 200433, China.
10Department of Gastroenterology, Changhai Clinical Research Unit, Changhai Hospital; National Key Laboratory of Immunity and Inflammation, Naval Medical University, Shanghai, 200433, China; Shanghai Institute of Pancreatic Diseases, Shanghai, 200433, China.

Continue reading
0